Skip to main content

Table 3 Treatment and covariate effects on unfavourable outcome for women (N = 426)

From: Gender differences in tuberculosis treatment outcomes: a post hoc analysis of the REMoxTB study

  r/n OR (unadjusted), 95% CI p aOR (adjusted), 95% CI p
Treatment
 HRZE 10/138     
 2MHRZ/2MHR 11/149 0.98 (0.40–2.43) 0.973
 2EMRZ/2MR 18/139 1.93 (0.84–4.39) 0.119   
Age
 ≤ 30 years 20/223 1.0  
 > 30 years 19/203 0.95 (0.48–1.88) 0.881   
BMI
 < 18.5 19/189 1.0  
 ≥ 18.5 20/237 1.03 (0.51–2.12) 0.926   
Race
 Asian 15/135 1.0    
 Black 9/163 0.39 (0.14–1.08) 0.070
 Mixed race and Caucasian 15/128 0.45 (0.14–1.45) 0.182   
Smoking
 Never smoked 21/292 1.0   1.0  
 Ever smoked 18/134 2.69 (0.92–7.90) 0.071 2.00 (1.03–3.90) 0.041
HIV
 Negative 36/385 1.0  
 Positive 3/41 1.16 (0.28–4.84) 0.835   
Cavities
 No cavities 9/110 1.0  
 Cavities 30/316 1.16 (0.51–2.63) 0.715